Peter Libby Google Scholar: h-index, Total Citations, and Citation Map
Peter Libby's h-index is 280 (1013 i10-index, 358,390+ total citations across 100+ publications) according to Google Scholar as of November 2026.
Peter Libby is a researcher affiliated with their institution, specializing in medicine, cardiology, atherosclerosis. Their work has been cited 358,390 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Peter Libby's Citation Metrics
Bibliometric impact based on 100 indexed publications.
- H-Index
- 280
- i10-Index
- 1013
- Total Citations
- 358,390
- Citing Countries
- 91
As of November 2026.
Peter Libby has an h-index of 280 and 358,390 total citations across 100 publications, with research cited by institutions in 91 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Peter Libby's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Inflammation and atherosclerosis
200225,045
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
1 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher authored a seminal, highly cited textbook chapter or section in the 12th edition of Braunwald's Heart Disease, establishing a definitive reference standard in cardiovascular medicine.
The researcher published a seminal NEJM study on canakinumab for atherosclerotic disease, establishing a critical link between inflammation and cardiovascular outcomes with over 10,000 citations.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Peter Libby's research
Peter Libby is a researcher working on medicine, cardiology and atherosclerosis. Their work has been cited 358,390 times across 100 publications (h-index 280), according to Google Scholar.
Their most-cited work, “Inflammation and atherosclerosis” (2002), has accumulated 25,045 citations. Other influential work includes “Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease” (2017) with 11,481 citations.
Citations of Peter Libby's research come primarily from China, United States and United Kingdom, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
